Sage Therapeutics Announces Third Quarter 2016 Financial Results and Provides SRSE European Update

Go back to Sage Therapeutics Announces Third Quarter 2016 Financial Results and Provides SRSE European Update
Sagebrush Gold Ltd. (NASDAQ: SAGE) Delayed: 8.68 --0 (-0%)
Previous Close $8.68    52 Week High $62.64 
Open $8.68    52 Week Low $26.28 
Day High $8.68    P/E N/A 
Day Low $8.68    EPS $-0.94 
Volume 333,782